Diagnosis of insulin resistance and associated syndromes: the spectrum from the metabolic syndrome to type 2 diabetes mellitus

被引:24
作者
Simonson, GD
Kendall, DM
机构
[1] Int Diabet Ctr, Minneapolis, MN 55416 USA
[2] Univ Minnesota, Sch Med, Minneapolis, MN 55455 USA
关键词
cardiovascular disease; insulin resistance; insulin resistance syndrome; metabolic syndrome; type; 2; diabetes;
D O I
10.1097/00019501-200512000-00002
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Insulin resistance is a common underlying physiologic abnormality associated with central obesity, type 2 diabetes and cardiovascular disease. Clinically, its hallmark markers of hypertension, glucose intolerance and dyslipidemia have been grouped into associated syndromes of insulin resistance. Insulin resistance is now considered a useful marker of clinical risk and a target for therapeutic intervention. While the criteria for diagnosis of syndromes related to insulin resistance have been established, the clinical diagnosis of insulin resistance remains a significant challenge. As more clinicians focus on the management of insulin resistance in patients with cardiovascular disease, type 2 diabetes and other syndromes of insulin resistance, its diagnosis will take on increasing importance. This review focuses on the current definition and diagnosis of insulin resistance and associated syndromes.
引用
收藏
页码:465 / 472
页数:8
相关论文
共 50 条
  • [41] Diagnosis, treatment and prevention of type 2 diabetes mellitus in children and adolescents
    Serbis, Anastasios
    Giapros, Vasileios
    Kotanidou, Eleni P.
    Galli-Tsinopoulou, Assimina
    Siomou, Ekaterini
    WORLD JOURNAL OF DIABETES, 2021, 12 (04) : 344 - 365
  • [42] Osteoprotegerin is independently associated with metabolic syndrome and microvascular complications in type 2 diabetes mellitus
    Tavintharan, S.
    Pek, Li Ting Sharon
    Liu, Jian Jun
    Ng, Xiao Wei
    Yeoh, Lee Ying
    Lim, Su Chi
    Sum, Chee Fang
    DIABETES & VASCULAR DISEASE RESEARCH, 2014, 11 (05) : 359 - 362
  • [43] Adiponectin, insulin resistance and clinical expression of the metabolic syndrome in patients with Type 2 diabetes
    O A Mojiminiyi
    N A Abdella
    M Al Arouj
    A Ben Nakhi
    International Journal of Obesity, 2007, 31 : 213 - 220
  • [44] Comparison of McAuley/fasting insulin indices with ATP III clinical criteria for the diagnosis of insulin resistance in type 2 diabetes mellitus
    Hettihewa, L. M.
    Weerarathna, T. P.
    JOURNAL OF PHARMACOLOGY & PHARMACOTHERAPEUTICS, 2011, 2 (03) : 165 - 169
  • [45] Pathophysiology of the Metabolic Syndrome: Implications for the Cardiometabolic Risks Associated With Type 2 Diabetes
    Leroith, Derek
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2012, 343 (01) : 13 - 16
  • [46] Plasma calprotectin and its association with cardiovascular disease manifestations, obesity and the metabolic syndrome in type 2 diabetes mellitus patients
    Pedersen, Lise
    Nybo, Mads
    Poulsen, Mikael Kjaer
    Henriksen, Jan Erik
    Dahl, Jordi
    Rasmussen, Lars Melholt
    BMC CARDIOVASCULAR DISORDERS, 2014, 14
  • [47] Relationship between the metabolic syndrome and the insulin resistance in adults with type 2 diabetes risk
    Ignacio Coniglio, Raul
    Ferraris, Roberto
    Prieto, Andrea
    Alberto Vasquez, Luis
    Garro, Sandra
    Antonio Tripodi, Marco
    Maria Salgueiro, Ana
    Carlos Otero, Juan
    Marcela Malaspina, Maria
    Montiel, Hugo
    ACTA BIOQUIMICA CLINICA LATINOAMERICANA, 2013, 47 (01): : 25 - 35
  • [48] Assessing the predictive value of insulin resistance indices for metabolic syndrome risk in type 2 diabetes mellitus patients
    Bazyar, Hadi
    Javid, Ahmad Zare
    Masoudi, Mahmood Reza
    Haidari, Fatemeh
    Heidari, Zeinab
    Hajializadeh, Sohrab
    Aghamohammadi, Vahideh
    Vajdi, Mehdi
    SCIENTIFIC REPORTS, 2024, 14 (01)
  • [49] Role of the inflammasome in insulin resistance and type 2 diabetes mellitus
    Lu, Shen
    Li, Yanrong
    Qian, Zhaojun
    Zhao, Tiesuo
    Feng, Zhiwei
    Weng, Xiaogang
    Yu, Lili
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [50] Hypothalamic arousal, insulin resistance and Type 2 diabetes mellitus
    Björntorp, P
    Holm, G
    Rosmond, R
    DIABETIC MEDICINE, 1999, 16 (05) : 373 - 383